{"id":"https://openalex.org/W4380029640","doi":"https://doi.org/10.1158/1538-7445.am2023-1865","title":"Abstract 1865: Development of CTIM-76, a highly specific Claudin 6 bispecific antibody for treatment of ovarian cancer","display_name":"Abstract 1865: Development of CTIM-76, a highly specific Claudin 6 bispecific antibody for treatment of ovarian cancer","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4380029640","doi":"https://doi.org/10.1158/1538-7445.am2023-1865"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2023-1865","doi":"https://doi.org/10.1158/1538-7445.am2023-1865","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-1865","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112235589","display_name":"Joseph B. Rucker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140826","display_name":"Integral Molecular (United States)","ror":"https://ror.org/056pdk382","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140826"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Rucker","raw_affiliation_strings":["1Integral Molecular, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Integral Molecular, Philadelphia, PA;","institution_ids":["https://openalex.org/I4210140826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021339320","display_name":"Ileine M. Sanchez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140826","display_name":"Integral Molecular (United States)","ror":"https://ror.org/056pdk382","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140826"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ileine Sanchez","raw_affiliation_strings":["1Integral Molecular, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Integral Molecular, Philadelphia, PA;","institution_ids":["https://openalex.org/I4210140826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022558900","display_name":"Kyle Doolan","orcid":"https://orcid.org/0000-0001-8449-4826","observed_orcids":["https://orcid.org/0000-0001-8449-4826"]},"institutions":[{"id":"https://openalex.org/I4210140826","display_name":"Integral Molecular (United States)","ror":"https://ror.org/056pdk382","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140826"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kyle Doolan","raw_affiliation_strings":["1Integral Molecular, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Integral Molecular, Philadelphia, PA;","institution_ids":["https://openalex.org/I4210140826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057083930","display_name":"Breanna Tyrell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140826","display_name":"Integral Molecular (United States)","ror":"https://ror.org/056pdk382","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140826"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Breanna Tyrell","raw_affiliation_strings":["1Integral Molecular, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Integral Molecular, Philadelphia, PA;","institution_ids":["https://openalex.org/I4210140826"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Anna Lobley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140826","display_name":"Integral Molecular (United States)","ror":"https://ror.org/056pdk382","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140826"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anna Lobley","raw_affiliation_strings":["1Integral Molecular, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Integral Molecular, Philadelphia, PA;","institution_ids":["https://openalex.org/I4210140826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014365564","display_name":"Nicholas M. Molino","orcid":"https://orcid.org/0000-0002-8120-3453","observed_orcids":["https://orcid.org/0000-0002-8120-3453"]},"institutions":[{"id":"https://openalex.org/I4210140826","display_name":"Integral Molecular (United States)","ror":"https://ror.org/056pdk382","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140826"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas Molino","raw_affiliation_strings":["1Integral Molecular, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Integral Molecular, Philadelphia, PA;","institution_ids":["https://openalex.org/I4210140826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047839063","display_name":"Kristen Erika Shema","orcid":"https://orcid.org/0000-0003-0723-6852","observed_orcids":["https://orcid.org/0000-0003-0723-6852"]},"institutions":[{"id":"https://openalex.org/I4210140826","display_name":"Integral Molecular (United States)","ror":"https://ror.org/056pdk382","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140826"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristen Shema","raw_affiliation_strings":["1Integral Molecular, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Integral Molecular, Philadelphia, PA;","institution_ids":["https://openalex.org/I4210140826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029770616","display_name":"Kyle Guldner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140826","display_name":"Integral Molecular (United States)","ror":"https://ror.org/056pdk382","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140826"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kyle Guldner","raw_affiliation_strings":["1Integral Molecular, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Integral Molecular, Philadelphia, PA;","institution_ids":["https://openalex.org/I4210140826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108873826","display_name":"Hayley Roth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140826","display_name":"Integral Molecular (United States)","ror":"https://ror.org/056pdk382","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140826"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hayley Roth","raw_affiliation_strings":["1Integral Molecular, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Integral Molecular, Philadelphia, PA;","institution_ids":["https://openalex.org/I4210140826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000106917","display_name":"Alyssa Cunningham","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140826","display_name":"Integral Molecular (United States)","ror":"https://ror.org/056pdk382","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140826"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alyssa Cunningham","raw_affiliation_strings":["1Integral Molecular, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Integral Molecular, Philadelphia, PA;","institution_ids":["https://openalex.org/I4210140826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092124306","display_name":"Kate Slovik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140826","display_name":"Integral Molecular (United States)","ror":"https://ror.org/056pdk382","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140826"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kate Slovik","raw_affiliation_strings":["1Integral Molecular, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Integral Molecular, Philadelphia, PA;","institution_ids":["https://openalex.org/I4210140826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023780575","display_name":"Riley J. Payne","orcid":"https://orcid.org/0000-0002-4179-4746","observed_orcids":["https://orcid.org/0000-0002-4179-4746"]},"institutions":[{"id":"https://openalex.org/I4210140826","display_name":"Integral Molecular (United States)","ror":"https://ror.org/056pdk382","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140826"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Riley Payne","raw_affiliation_strings":["1Integral Molecular, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Integral Molecular, Philadelphia, PA;","institution_ids":["https://openalex.org/I4210140826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084740629","display_name":"Eric A. Butz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eric Butz","raw_affiliation_strings":["2Cascadia Drug Development Group, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Cascadia Drug Development Group, Philadelphia, PA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Evan Dick","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Evan Dick","raw_affiliation_strings":["3Context Therapeutics, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Context Therapeutics, Philadelphia, PA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069147730","display_name":"Ed Calamai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edward Calamai","raw_affiliation_strings":["3Context Therapeutics, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Context Therapeutics, Philadelphia, PA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077283279","display_name":"Ross Chambers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140826","display_name":"Integral Molecular (United States)","ror":"https://ror.org/056pdk382","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140826"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ross Chambers","raw_affiliation_strings":["1Integral Molecular, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Integral Molecular, Philadelphia, PA;","institution_ids":["https://openalex.org/I4210140826"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"7_Supplement","first_page":"1865","last_page":"1865"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9185000061988831,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9185000061988831,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.026900000870227814,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/claudin-6","display_name":"CLDN6","score":0.8889999985694885},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.8330000042915344},{"id":"https://openalex.org/keywords/t-cell-engagers","display_name":"T-cell engagers","score":0.9100000262260437},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9279999732971191},{"id":"https://openalex.org/keywords/endometrial-cancer","display_name":"endometrial cancer","score":0.9589999914169312},{"id":"https://openalex.org/keywords/tight-junction-proteins","display_name":"tight junction proteins","score":0.6880000233650208},{"id":"https://openalex.org/keywords/cd3","display_name":"CD3","score":0.6259999871253967},{"id":"https://openalex.org/keywords/antibody-engineering","display_name":"antibody engineering","score":0.6919999718666077},{"id":"https://openalex.org/keywords/t-cell-mediated-cytotoxicity","display_name":"T cell cytotoxicity","score":0.7919999957084656},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.597000002861023},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.6259999871253967},{"id":"https://openalex.org/keywords/developability","display_name":"developability","score":0.6399999856948853}],"concepts":[{"id":"https://openalex.org/C51872919","wikidata":"https://www.wikidata.org/wiki/Q420863","display_name":"Claudin","level":3,"score":0.7583556175231934},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6887340545654297},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6817948222160339},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6188036203384399},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.5739424228668213},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5359628200531006},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4902270436286926},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4543662369251251},{"id":"https://openalex.org/C177779419","wikidata":"https://www.wikidata.org/wiki/Q1053832","display_name":"Tight junction","level":2,"score":0.4445110857486725},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.36917516589164734},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.1617169976234436},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07039374113082886}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2023-1865","doi":"https://doi.org/10.1158/1538-7445.am2023-1865","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-1865","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8500000238418579}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4282973285","https://openalex.org/W4388048303","https://openalex.org/W4410809847","https://openalex.org/W3177980155","https://openalex.org/W7134849862","https://openalex.org/W4409636136","https://openalex.org/W4409636120","https://openalex.org/W4293053587","https://openalex.org/W4403386962","https://openalex.org/W3180879899"],"abstract_inverted_index":{"Abstract":[0],"Solid":[1],"tumors":[2,20],"lead":[3,273],"to":[4,37,112,115,158,212,245,313],"580,000":[5],"deaths":[6],"annually":[7],"in":[8,95,151,217,224,227,255,260,263],"the":[9,137,218,311,315,383],"US,":[10],"and":[11,13,31,57,82,123,163,197,204,226,234,257,300,303,323,395],"safe":[12],"effective":[14],"therapeutics":[15],"for":[16,73,127,276,317,321,374,386],"many":[17,32,74],"late-stage":[18],"solid":[19,59,75],"are":[21,110,210],"lacking.":[22],"Ovarian":[23],"cancer":[24,89,378],"alone":[25],"kills":[26],"14,000":[27],"people":[28],"each":[29],"year,":[30],"patients":[33],"do":[34],"not":[35],"respond":[36],"currently":[38],"available":[39],"treatments.":[40],"Here":[41],"we":[42,181,270],"introduce":[43],"CTIM-76,":[44,366],"a":[45,51,69,174,183,214,247,272,281,367],"CLDN6":[46,109,134,149,179],"T-cell":[47],"engager":[48],"antibody":[49,373],"as":[50,207,238,240],"potential":[52,312],"treatment":[53,375],"of":[54,118,133,176,188,220,250,283,286,291,308,365,376,382],"ovarian,":[55,79],"endometrial,":[56,80],"other":[58,159,294,324],"tumors.":[60],"The":[61,130,147,305],"tight":[62],"junction":[63],"protein":[64],"Claudin":[65,370],"6":[66,371],"(CLDN6)":[67],"is":[68,85],"validated":[70],"therapeutic":[71,104,319],"target":[72],"tumor":[76],"types,":[77],"including":[78],"testicular,":[81],"gastric.":[83],"It":[84],"differentially":[86],"expressed":[87,139],"on":[88],"cells":[90,292],"with":[91,173],"no":[92,289],"reported":[93],"expression":[94],"normal,":[96],"healthy":[97],"tissue.":[98],"Despite":[99],"being":[100],"an":[101,116,124],"attractive":[102],"target,":[103],"monoclonal":[105],"antibodies":[106,191],"(MAbs)":[107],"targeting":[108],"difficult":[111],"discover":[113],"due":[114],"abundance":[117],"closely":[119,135,295],"related":[120,296],"family":[121,140,161,298],"members":[122,162],"absolute":[125],"need":[126,316],"high":[128],"specificity.":[129],"extracellular":[131],"region":[132],"resembles":[136],"widely":[138],"member":[141],"CLDN9":[142],"(3":[143],"amino":[144],"acids":[145],"different).":[146],"few":[148],"MAbs":[150],"clinical":[152],"development":[153],"have":[154,165],"demonstrated":[155,258],"significant":[156],"binding":[157,205],"CLDN":[160],"most":[164],"now":[166],"been":[167],"halted":[168],"from":[169],"further":[170],"development.":[171],"Starting":[172],"panel":[175,249],"highly":[177,368],"specific":[178,369],"antibodies,":[180],"engineered":[182],"large":[184],"set":[185],"(>":[186],"50)":[187],"CLDN6xCD3":[189],"bispecific":[190,372],"(CLDN6":[192],"bispecifics)":[193],"using":[194],"multiple":[195],"formats":[196],"CD3":[198],"arms":[199],"that":[200],"encompass":[201],"different":[202],"geometries":[203],"stoichiometries,":[206],"these":[208,221],"factors":[209],"expected":[211],"play":[213],"critical":[215],"role":[216],"potency":[219],"molecules":[222],"both":[223],"vitro":[225,230],"vivo.":[228],"In":[229],"T":[231],"cell":[232],"cytotoxicity":[233],"cytokine":[235],"release":[236],"assays":[237],"well":[239],"developability":[241],"studies":[242,262],"were":[243,253],"used":[244],"select":[246],"small":[248],"antibodies.":[251],"These":[252],"tested":[254],"vivo":[256],"efficacy":[259],"xenograft":[261],"PBMC-engrafted":[264],"mice.":[265],"From":[266],"this":[267],"smaller":[268],"panel,":[269],"chose":[271],"molecule,":[274],"CTIM-76":[275,279,309],"IND-enabling":[277],"studies.":[278],"shows":[280],"combination":[282],"potent":[284,318],"killing":[285,290],"CLDN6-expressing":[287],"cells,":[288],"expressing":[293],"claudin":[297],"members,":[299],"excellent":[301],"productivity":[302],"developability.":[304],"exquisite":[306],"specificity":[307],"suggests":[310],"address":[314],"modalities":[320],"ovarian":[322,377],"cancers":[325],"without":[326],"compromising":[327],"patient":[328],"safety.":[329],"Citation":[330],"Format:":[331],"Joseph":[332],"Rucker,":[333],"Ileine":[334],"Sanchez,":[335],"Kyle":[336,346],"Doolan,":[337],"Breanna":[338],"Tyrell,":[339],"Anna":[340],"Lobley,":[341],"Nicholas":[342],"Molino,":[343],"Kristen":[344],"Shema,":[345],"Guldner,":[347],"Hayley":[348],"Roth,":[349],"Alyssa":[350],"Cunningham,":[351],"Kate":[352],"Slovik,":[353],"Riley":[354],"Payne,":[355],"Eric":[356],"Butz,":[357],"Evan":[358],"Dick,":[359],"Edward":[360],"Calamai,":[361],"Ross":[362],"Chambers.":[363],"Development":[364],"[abstract].":[379],"In:":[380],"Proceedings":[381],"American":[384],"Association":[385],"Cancer":[387,406],"Research":[388],"Annual":[389],"Meeting":[390],"2023;":[391],"Part":[392],"1":[393],"(Regular":[394],"Invited":[396],"Abstracts);":[397],"2023":[398],"Apr":[399],"14-19;":[400],"Orlando,":[401],"FL.":[402],"Philadelphia":[403],"(PA):":[404],"AACR;":[405],"Res":[407],"2023;83(7_Suppl):Abstract":[408],"nr":[409],"1865.":[410]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2023-06-10T00:00:00"}